garcinol has been researched along with Colitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ho, CT; Lee, PS; Nagabhushanam, K; Pan, MH | 1 |
| Jiang, YW; Kim, NM; Li, B; Liang, R; Lu, Y; Xu, HX; Zhang, H; Zheng, D; Zhu, FX | 1 |
| Chiou, LY; Chiou, YS; Ho, CT; Pan, MH; Tsai, ML | 1 |
3 other study(ies) available for garcinol and Colitis
| Article | Year |
|---|---|
Inhibitory Effect of Garcinol on Obesity-Exacerbated, Colitis-Mediated Colon Carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Biomarkers; Cell Proliferation; Colitis; Colonic Neoplasms; Cytokines; Dextran Sulfate; Diet, High-Fat; Disease Models, Animal; Dysbiosis; Gastrointestinal Microbiome; Gene Expression Regulation, Neoplastic; Lipids; Male; Mice, Inbred C57BL; Obesity; Organ Size; Proliferating Cell Nuclear Antigen; Terpenes | 2021 |
Cambogin suppresses dextran sulphate sodium-induced colitis by enhancing Treg cell stability and function.
Topics: Animals; Anti-Inflammatory Agents; Colitis; Colon; Cytokines; Dextran Sulfate; Female; Forkhead Transcription Factors; HEK293 Cells; Humans; Mice; T-Lymphocytes, Regulatory; Terpenes | 2018 |
Garcinol suppresses inflammation-associated colon carcinogenesis in mice.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; beta Catenin; Colitis; Colonic Neoplasms; Dextran Sulfate; Hepatitis; Inflammation Mediators; Lipid Metabolism; Male; Mice, Inbred ICR; Neoplasms, Experimental; Signal Transduction; Terpenes | 2014 |